pdufa.bio

Suzetrigine

Page updated ·next FDA decision on the calendar ·Data as of Oct 11, 2026 9:31 PM ET

Suzetrigine The FDA approved it on Jan 30, 2025. 1 FDA decision on record below. Every date links its source.

VRTX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

FDA decision · Jan 30, 2025 ✓ ApprovedVRTX

Questions

When is Suzetrigine's next FDA decision or readout?

No upcoming catalyst is on our calendar for Suzetrigine; 1 FDA decision is on record below.

What happened at Suzetrigine's most recent FDA decision?

On Jan 30, 2025 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.

Has Suzetrigine been approved by the FDA?

Yes. The FDA approved an application for Suzetrigine on Jan 30, 2025; the decision page linked above carries the source.

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.